Zaleplon
- Product NDC
- 71335-1466
- 11-digit product format
- 713351466
- Labeler code
- 71335
- Product ID
- 71335-1466_5482ea84-3aa9-4d4d-9344-f51a6998dca4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zaleplon
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090374
- Marketing category
- ANDA
- Marketing start
- 2018-06-20
- Marketing end
- 0000-00-00
- Substance
- ZALEPLON
- Active strength
- 5 mg/1
- Pharmacologic classes
- Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1466-1 | 71335146601 | 30 CAPSULE in 1 BOTTLE (71335-1466-1) | 30 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |
| 71335-1466-2 | 71335146602 | 60 CAPSULE in 1 BOTTLE (71335-1466-2) | 60 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |
| 71335-1466-3 | 71335146603 | 90 CAPSULE in 1 BOTTLE (71335-1466-3) | 90 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |
| 71335-1466-4 | 71335146604 | 20 CAPSULE in 1 BOTTLE (71335-1466-4) | 20 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |
| 71335-1466-5 | 71335146605 | 28 CAPSULE in 1 BOTTLE (71335-1466-5) | 28 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |